Skip to main content

Table 1 Association between BCAR1 staining and prostate cancer clinical characteristics

From: High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

Parameter BCAR1 (%)
  N evaluable Negative Weak Moderate Strong P value
All cancers 9472 22.4 15.9 23.2 38.5  
Tumor stage
 pT2 6170 23.7 15.9 23.1 37.4 0.0082
 pT3a 2138 20.4 16.1 24.2 39.3
 pT3b-pT4 1160 19.5 15.6 21.7 43.2
Gleason score
 ≤ 3 + 3 2186 27.2 19.0 23.1 30.8 < 0.0001
 3 + 4 5133 21.9 14.9 23.5 39.8
 3 + 4 Tertiary 5 345 22.9 14.5 23.8 38.8
 4 + 3 893 18.4 17.6 21.7 42.3
 4 + 3 Tertiary 5 464 15.1 14.4 22.4 48.1
 ≥ 4 + 4 445 20.9 11.7 23.2 44.3
Lymph node metastasis
 N0 5262 20.9 16.1 23.2 40.0 <0.0001
 N+ 494 21.3 12.8 21.5 44.5
Preoperative PSA level (ng/ml)
 < 4 1480 16.9 15.0 24.0 44.1 <0.0001
 4–10 5475 21.6 15.9 23.5 39.0
 10–20 1817 26.0 15.9 22.5 35.6
 > 20 638 32.1 17.6 19.0 31.4
Surgical margin
 Negative 7566 22.1 15.8 23.3 38.8 <0.0001
 Positive 1794 23.4 16.2 22.9 37.6